Matthew Plavan
2021 - Arcadia Biosciences
In 2021, Matthew Plavan earned a total compensation of $1.6M as Former President and Chief Executive Officer at Arcadia Biosciences, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $81,612 |
|---|---|
| Option Awards | $813,784 |
| Salary | $443,998 |
| Other | $266,610 |
| Total | $1,606,004 |
Plavan received $813.8K in option awards, accounting for 51% of the total pay in 2021.
Plavan also received $81.6K in non-equity incentive plan, $444K in salary and $266.6K in other compensation.
Rankings
In 2021, Matthew Plavan's compensation ranked 6,958th out of 12,405 executives tracked by ExecPay. In other words, Plavan earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,958 out of 12,405 | 44th |
Division Agriculture, Forestry, And Fishing | 28 out of 66 | 58th |
Major group Agricultural Production Crops | 23 out of 45 | 49th |
Source: SEC filing on April 19, 2022.
Plavan's colleagues
We found three more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2021.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019